Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.

Muñoz García, D; Midaglia, L; Martinez Vilela, J; Marín Sánchez, M; López González, F J; Arias Gómez, M; Dapena Bolaño, D; Iglesias Castañón, A; Alonso Alonso, M; Romero López, J

Muñoz García, D; Midaglia, L; Martinez Vilela, J; Marín Sánchez, M; López González, F J; Arias Gómez, M; Dapena Bolaño, D; Iglesias Castañón, A; Alonso Alonso, M; Romero López, J.

Affiliation

Muñoz García D; Neurology Department, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.

Acta Neurol Scand ; 131(6): 405-10, 2015 Jun.

Article in En | MEDLINE | ID: mdl-25313094

Subject(s)

Inosine/therapeutic use; Interferons/therapeutic use; Multiple Sclerosis/drug therapy; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inosine/administration & dosage; Inosine/adverse effects; Interferons/administration & dosage; Male; Middle Aged

Key words

antioxidant; inosine; interferon beta-1a; multiple sclerosis; neuroprotection; uric acid

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferons / Inosine / Multiple Sclerosis Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Neurol Scand Year: 2015 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google